> Detailanzeige
Bastard, Paul;
Rosen, Lindsey B.;
Zhang, Qian;
Michailidis, Eleftherios;
Hoffmann, Hans-Heinrich;
Zhang, Yu;
Dorgham, Karim;
Philippot, Quentin;
Rosain, Jérémie;
Béziat, Vivien;
Manry, Jérémy;
Shaw, Elana;
Haljasmägi, Liis;
Peterson, Pärt;
Lorenzo, Lazaro;
Bizien, Lucy;
Trouillet-Assant, Sophie;
Dobbs, Kerry;
de Jesus, Adriana Almeida;
Belot, Alexandre;
Kallaste, Anne;
Catherinot, Emilie;
Tandjaoui-Lambiotte, Yacine;
Le Pen, Jeremie;
[...]
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Teilen
Literatur-
verwaltung
Direktlink
Zur
Merkliste
Lösche von
Merkliste
Per Email teilen
Auf Twitter teilen
Auf Facebook teilen
Per Whatsapp teilen
- Medientyp: E-Artikel
- Titel: Autoantibodies against type I IFNs in patients with life-threatening COVID-19
- Beteiligte: Bastard, Paul; Rosen, Lindsey B.; Zhang, Qian; Michailidis, Eleftherios; Hoffmann, Hans-Heinrich; Zhang, Yu; Dorgham, Karim; Philippot, Quentin; Rosain, Jérémie; Béziat, Vivien; Manry, Jérémy; Shaw, Elana; Haljasmägi, Liis; Peterson, Pärt; Lorenzo, Lazaro; Bizien, Lucy; Trouillet-Assant, Sophie; Dobbs, Kerry; de Jesus, Adriana Almeida; Belot, Alexandre; Kallaste, Anne; Catherinot, Emilie; Tandjaoui-Lambiotte, Yacine; Le Pen, Jeremie; [...]
-
Erschienen:
American Association for the Advancement of Science (AAAS), 2020
- Erschienen in: Science, 370 (2020) 6515
- Sprache: Englisch
- DOI: 10.1126/science.abd4585
- ISSN: 0036-8075; 1095-9203
- Entstehung:
- Anmerkungen:
- Beschreibung: The genetics underlying severe COVID-19 The immune system is complex and involves many genes, including those that encode cytokines known as interferons (IFNs). Individuals that lack specific IFNs can be more susceptible to infectious diseases. Furthermore, the autoantibody system dampens IFN response to prevent damage from pathogen-induced inflammation. Two studies now examine the likelihood that genetics affects the risk of severe coronavirus disease 2019 (COVID-19) through components of this system (see the Perspective by Beck and Aksentijevich). Q. Zhang et al. used a candidate gene approach and identified patients with severe COVID-19 who have mutations in genes involved in the regulation of type I and III IFN immunity. They found enrichment of these genes in patients and conclude that genetics may determine the clinical course of the infection. Bastard et al. identified individuals with high titers of neutralizing autoantibodies against type I IFN-α2 and IFN-ω in about 10% of patients with severe COVID-19 pneumonia. These autoantibodies were not found either in infected people who were asymptomatic or had milder phenotype or in healthy individuals. Together, these studies identify a means by which individuals at highest risk of life-threatening COVID-19 can be identified. Science , this issue p. eabd4570 , p. eabd4585 ; see also p. 404